Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China
Active Case Finding Using Mobile Vans Equipped With Artificial Intelligence Aided Radiology Tests and Sputum Collection for Rapid Diagnostic Tests to Reduce Tuberculosis Prevalence Among High-risk Populations in Rural China: a Pragmatic Cluster Randomized Controlled Trial
1 other identifier
interventional
72,000
1 country
1
Brief Summary
The goal of this study is to find out if using mobile vans with advanced technology can help reduce tuberculosis (TB) in rural Guangxi, China. The study will also examine how practical and cost-effective this approach is. The main questions it aims to answer are: 1) Does this new screening method lower the number of TB cases among high-risk groups? and 2) Is this method practical and acceptable for communities and healthcare workers? Participants in the study will: 1) undergo TB screening with mobile vans that use artificial intelligence (AI) to read chest X-rays, 2) answer a short questionnaire about their symptoms and health history, and 3) provide sputum samples for GeneXpert testing if needed. Some communities will receive the new screening method, while others will continue with usual care. Researchers will compare TB rates in the two groups over three years to see if the new approach works better for TB control. If successful, this method could be used to improve TB control in other areas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 20, 2021
CompletedFirst Submitted
Initial submission to the registry
November 20, 2024
CompletedFirst Posted
Study publicly available on registry
November 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedDecember 6, 2024
December 1, 2024
3.2 years
November 20, 2024
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence rate of bacteriologically positive TB
Prevalence rate of bacteriologically positive TB in Year 3 among the high-risk populations , including those of 65 and older, those who are under 65 but have a history of tuberculosis treatment or have been in close contact with a person diagnosed of TB within the past three years, have been clinically diagnosed with diabetes, HIV, or have a background of working as a miner.
In year 3 after recruitment
Secondary Outcomes (3)
Prevalence rate of active TB
In Year 3 after recruitment
Notification rates of bacteriologically positive TB
In Year 3 after recruitment
Notification rates of active TB cases
In Year 3 after recruitment
Study Arms (2)
Intervention
EXPERIMENTALA single active case finding campaign for Tuberculosis will occur in Year 1 alongside the usual care.
Control
NO INTERVENTIONUsual care will be provided and no active case finding activities will be implemented.
Interventions
Villagers will be informed through public announcements and social workers. Before the campaign, social workers and village doctors will recruit participants and obtain consent through door-to-door visits. A mobile van equipped with an AI-assisted digital radiography (DR) machine and a refrigerator will visit villages on agreed dates. Participants will complete a TB symptom questionnaire and undergo DR screening. Those with TB symptoms or abnormal DR results will provide on-site sputum samples and collect additional morning and night samples. Trained staff will ensure proper collection and offer nebulizer support if needed. Samples will be transported daily to hospitals for testing using smear, culture, and GeneXpert. Participants with negative bacteriological results but abnormal findings will be referred for further clinical assessment.
Eligibility Criteria
You may qualify if:
- all residents who are elderly (i.e., aged 65 and above)
- all residents who are aged 15 to 64 with one of the following conditions: being patients previously treated for TB or close contacts of a patient with a TB patient diagnosed within the last three years; having been clinically diagnosed with diabetes, HIV positive, or worked as a miner
- Have signed consent form
You may not qualify if:
- Residents who refuse participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Nanning, Guangxi, 530000, China
Related Publications (1)
Wei X, Liang D, Zhang Z, Thorpe KE, Zhou L, Zhao J, Qin H, Liang X, Cui Z, Huang Y, Huang L, Lin M. Active case finding using mobile vans with artificial intelligence aided radiology tests and sputum collection for rapid diagnostic tests to reduce tuberculosis prevalence among high-risk population in rural China: Protocol for a pragmatic trial. PLoS One. 2025 Apr 11;20(4):e0316073. doi: 10.1371/journal.pone.0316073. eCollection 2025.
PMID: 40215230DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dabin Liang, PhD
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
- PRINCIPAL INVESTIGATOR
Xiaolin Wei, PhD
University of Toronto
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 20, 2024
First Posted
November 25, 2024
Study Start
November 20, 2021
Primary Completion
January 31, 2025
Study Completion
April 30, 2025
Last Updated
December 6, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data won't be publicly available due to local policy. Clustered data can be shared upon reasonable request to lxy530028@163.com for research purpose only after January 1, 2027.